Schunk M K, Percy D H, Rosendal S
Department of Pathology, Ontario Veterinary College, University of Guelph.
Can J Vet Res. 1995 Jan;59(1):60-6.
The effects of time of exposure on the progression of pulmonary lesions in rats inoculated with Mycoplasma pulmonis and the rat coronavirus, sialodacryoadenitis virus (SDAV) were studied, using six groups of 18 SPF Wistar rats (n = 108). Rats were inoculated intranasally as follows: Group 1, sterile medium only; Group 2, sterile medium followed one week later by 150 TCID50 SDAV; Group 3, sterile medium followed by 10(5.7) colony forming units of M. pulmonis; Group 4, SDAV followed one week later by M. pulmonis; Group 5, M. pulmonis followed one week later by SDAV; Group 6, M. pulmonis followed two weeks later by SDAV. Six rats from each group were euthanized at one, two and three weeks after the final inoculation. In a separate experiment, six additional animals were inoculated in each of groups 3, 5 and 6 (n = 18) and were sampled at five weeks after they had received M. pulmonis. Bronchoalveolar lavage and quantitative lung mycoplasma cultures were conducted on two-thirds of the rats. Histopathological examination and scoring of lesion severity were performed on all animals. Based on the prevalence and extent of histopathological lesions, bronchoalveolar lavage cell numbers, neutrophil differential cell counts and the isolation of M. pulmonis, the most severe disease occurred in the groups that received both agents. There was no significant difference in lesion severity between the groups receiving both agents other than in those examined during the acute stages of SDAV infection. Based on these results, it is evident that SDAV enhances lower respiratory tract disease in Wistar rats whether exposure occurs at one week prior to or at various intervals following M. pulmonis infections.
研究了暴露时间对接种肺炎支原体和大鼠冠状病毒——涎泪腺炎病毒(SDAV)的大鼠肺部病变进展的影响,使用六组18只无特定病原体(SPF)的Wistar大鼠(n = 108)。大鼠经鼻内接种如下:第1组,仅接种无菌培养基;第2组,先接种无菌培养基,一周后接种150个半数组织培养感染剂量(TCID50)的SDAV;第3组,先接种无菌培养基,然后接种10(5.7)个肺炎支原体菌落形成单位;第4组,先接种SDAV,一周后接种肺炎支原体;第5组,先接种肺炎支原体,一周后接种SDAV;第6组,先接种肺炎支原体,两周后接种SDAV。每组六只大鼠在最后一次接种后的1周、2周和3周时实施安乐死。在另一项实验中,第3、5和6组每组额外接种6只动物(n = 18),在它们接种肺炎支原体后5周进行采样。对三分之二的大鼠进行支气管肺泡灌洗和肺部支原体定量培养。对所有动物进行组织病理学检查并对病变严重程度进行评分。根据组织病理学病变的发生率和范围、支气管肺泡灌洗细胞数量、中性粒细胞分类计数以及肺炎支原体的分离情况,同时接受两种病原体的组中疾病最为严重。除了在SDAV感染急性期检查的组之外,接受两种病原体的组之间在病变严重程度上没有显著差异。基于这些结果,很明显,无论暴露是发生在肺炎支原体感染前一周还是在感染后的不同间隔时间,SDAV都会加重Wistar大鼠的下呼吸道疾病。